Lawlor Sally Bridgetinsider trades

In SEC Form 4 filings, Lawlor Sally Bridget is listed as Chief Financial Officer of Quoin Pharmaceuticals, Ltd. (QNRX). In the last 90 days, Lawlor Sally Bridget bought $50K of Quoin Pharmaceuticals, Ltd. (QNRX) on the open market and sold none. The purchase was $50K of Quoin Pharmaceuticals, Ltd. (QNRX) on Aug 31. Took part in a cluster buy; the latest at Quoin Pharmaceuticals, Ltd. (QNRX), where 4 insiders bought within 1 day, ending Aug 31.

Companies and roles

Company	Role	Transactions	Last filed
QNRXQuoin Pharmaceuticals, Ltd.	Chief Financial Officer	2	Sep 1

Cluster buys

QNRX: 4 insiders bought $280K between Aug 31.

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
QNRXQuoin Pharmaceuticals, Ltd.	Aug 31	Sep 1	P	10,244	$4.88	Purchase +$49,991	10,684	No	Form 4
QNRXQuoin Pharmaceuticals, Ltd.	Aug 31	Sep 1	P · derivative	5,122	$6.10	Purchase +$31,244	5,122	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.